Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

772
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
772
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.7K
The pathophysiology of pneumonia involves the following steps:
2.7K
Autoimmune Disorders01:29

Autoimmune Disorders

1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

775
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
775
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

802
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
802

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

ACR open rheumatology·2025
Same author

Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials.

Seminars in arthritis and rheumatism·2025
Same author

Abatacept for the treatment of myositis-associated interstitial lung disease.

Rheumatology (Oxford, England)·2025
Same author

Real-world antifibrotic treatment patterns in patients with idiopathic pulmonary fibrosis: retrospective analyses of two large healthcare administrative databases in the United States.

Therapeutic advances in respiratory disease·2024
Same author

Efficacy and Safety of Admilparant, an LPA<sub>1</sub> Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial.

American journal of respiratory and critical care medicine·2024
Same author

Circulating biomarker analyses in a longitudinal cohort of patients with IPF.

American journal of physiology. Lung cellular and molecular physiology·2024
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K

Interstitial Pneumonia with Autoimmune Features.

Aryeh Fischer1

  • 1Divisions of Rheumatology, Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, University of Colorado School of Medicine, 12631 East 17th Avenue, Academic Office Building One, Aurora, CO 80045, USA.

Clinics in Chest Medicine
|August 5, 2019
PubMed
Summary
This summary is machine-generated.

The new interstitial pneumonia with autoimmune features classification offers uniform criteria for these lung conditions. Further research is needed as some patients may develop defined connective tissue disease over time.

Keywords:
Connective tissue diseasesIdiopathic interstitial pneumoniasInterstitial lung diseasePulmonary fibrosis

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.9K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K

Related Experiment Videos

Last Updated: Jan 21, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.9K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K

Area of Science:

  • Pulmonology
  • Rheumatology
  • Immunology

Background:

  • Diverse nomenclature previously hindered consistent characterization of interstitial lung disease associated with autoimmune conditions.
  • The European Respiratory Society/American Thoracic Society proposed the interstitial pneumonia with autoimmune features (IPAF) classification to standardize terminology.
  • This classification aims to improve interdisciplinary communication and research efforts for these complex cases.

Purpose of the Study:

  • To review cohort studies on interstitial pneumonia with autoimmune features (IPAF).
  • To elucidate the phenotype of IPAF based on existing research.
  • To provide insights into future research directions for IPAF.

Main Methods:

  • Review of published cohort studies focusing on interstitial pneumonia with autoimmune features.
  • Analysis of patient phenotypes and clinical characteristics within these cohorts.
  • Synthesis of findings to inform future research strategies.

Main Results:

  • The IPAF classification provides uniform nomenclature and diagnostic criteria.
  • Cohort studies reveal diverse phenotypes within IPAF, highlighting the heterogeneity of these conditions.
  • Longitudinal data indicates a subset of IPAF patients may progress to a defined connective tissue disease.

Conclusions:

  • The IPAF classification represents a significant advancement in uniformly describing patients with autoimmune-associated interstitial lung disease.
  • Understanding IPAF phenotypes is crucial for accurate diagnosis and management.
  • Longitudinal surveillance is essential to monitor disease evolution and potential progression to defined connective tissue diseases.